What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
Sam Schulman mostly deals with Surgery, Internal medicine, Warfarin, Thrombosis and Anticoagulant.
His Surgery research includes themes of Vitamin K antagonist and Antithrombotic.
As part of one scientific family, Sam Schulman deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Vein, Factor V and Risk factor.
The Warfarin study combines topics in areas such as Stroke, Anesthesia and Heparin.
His Thrombosis study incorporates themes from Platelet activation, Randomized controlled trial and Gastrointestinal bleeding.
His Anticoagulant study combines topics from a wide range of disciplines, such as Cohort study, Endothelial dysfunction, Disease, Complication and Cohort.
His most cited work include:
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. (2082 citations)
- Dabigatran versus warfarin in the treatment of acute venous thromboembolism (1935 citations)
- Prevention of VTE in Nonsurgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (1849 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Surgery, Thrombosis, Warfarin and Intensive care medicine.
His Internal medicine study frequently links to adjacent areas such as Gastroenterology.
His work in the fields of Anticoagulant, Perioperative and Coagulopathy overlaps with other areas such as In patient.
His Thrombosis research integrates issues from Pulmonary embolism, Heparin and Hazard ratio.
His research integrates issues of Stroke, Anesthesia and Confidence interval in his study of Warfarin.
Sam Schulman combines subjects such as Anticoagulant therapy, MEDLINE and Antithrombotic with his study of Intensive care medicine.
He most often published in these fields:
- Internal medicine (50.79%)
- Surgery (41.33%)
- Thrombosis (29.07%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (50.79%)
- Thrombosis (29.07%)
- Venous thromboembolism (18.21%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Thrombosis, Venous thromboembolism, Intensive care medicine and Surgery.
His study in the field of Warfarin, Prospective cohort study, Randomized controlled trial and Confidence interval is also linked to topics like In patient.
Dabigatran is the focus of his Warfarin research.
His Thrombosis research is multidisciplinary, relying on both Hemostasis, Pulmonary embolism and Heparin.
The Intensive care medicine study which covers MEDLINE that intersects with Coronavirus disease 2019.
His work deals with themes such as Univariate analysis and Atrial fibrillation, which intersect with Surgery.
Between 2015 and 2021, his most popular works were:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study (141 citations)
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant (98 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Sam Schulman focuses on Internal medicine, Thrombosis, Surgery, Intensive care medicine and Pulmonary embolism.
Sam Schulman has included themes like MEDLINE and Antithrombotic in his Thrombosis study.
His Cohort study research extends to the thematically linked field of Surgery.
The various areas that he examines in his Intensive care medicine study include Anticoagulant and Heparin.
His Pulmonary embolism study combines topics from a wide range of disciplines, such as Incidence, Deep vein and Hazard ratio.
His work focuses on many connections between Warfarin and other disciplines, such as Anesthesia, that overlap with his field of interest in Dabigatran, Stroke and Alternative medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
